Rhythm Pharma: Incremental Approach Works Well For Setmelanotide
aykut karahan /iStock via Getty Images Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) is up 124% since my last, positive article in August. ...
Read moreTag: Pharma
Joe Rogan, Bill Maher trash big pharma, vaccines: ‘Don’t trust them’
Joe Rogan is back to vaccine-bashing. The podcasting provocateur interviewed premium cable pundit Bill Maher on “The Joe Rogan Experience” ...
Read more
FTC’s top economist resigned amid dispute over pharma study
The people, speaking anonymously to discuss internal agency deliberations, didn’t know Wosinska’s specific objections to the proposed study. She didn’t ...
Read moreMore Americans say they are "vaxxed and done" despite Omicron's spread
The highly contagious COVID-19 Omicron variant has spawned a rift among the fully vaccinated in the U.S., with some continuing ...
Read morePurdue Pharma owners up opioid settlement offer to $6 bn
The owners of Purdue Pharma, maker of OxyContin, have offered to pay up to $6 billion to victims of the ...
Read moreU.S. releases declassified COVID-19 origins report
A declassified U.S. intelligence report says that a natural origin and a lab leak were both possible hypotheses to explain ...
Read moreBiden urges Americans to get booster shots as concern spreads over Omicron variant
The Biden administration is working on its response to the Omicron variant as the Centers for Disease Control and Prevention ...
Read moreCovid vaccines deserve our trust – but big pharma doesn’t | Laura Spinney
Last week, a commission set up by Stanford University and the Lancet found that the devastating opioid crisis in North ...
Read moreU.S. administers 400 million COVID-19 vaccine doses as some states struggle with vaccinations
The U.S. has administered more than 400 million coronavirus vaccine doses. However, some states are still lagging behind in vaccination ...
Read more
MEI Pharma: Another PI3K Delta Progressing To The FDA (NASDAQ:MEIP)
Bulgac/E+ via Getty Images I covered MEI Pharma (MEIP) more than a year ago, and in what has become a ...
Read more
